Exercise Could Benefit Early-Stage Diabetic Cardiomyopathy, Review Finds
A review highlights the potential of exercise to help manage diabetic cardiomyopathy in its early stages, though more research is needed.
NEW DELHI, Nov 6: A review has indicated that exercise could be beneficial for managing diabetic cardiomyopathy, particularly in its initial stages. However, it emphasizes the need for more robust evidence to determine the most effective exercise programs and their long-term cardiovascular effects.
The review consolidates findings from both experimental and clinical studies on exercise’s impact on heart muscle dysfunction associated with diabetes. Diabetic cardiomyopathy leads to modifications in heart metabolism, fibrosis, and changes in calcium handling and heart structure, with limited strategies available to reverse established cardiac damage.
Research suggests that exercise may enhance mitochondrial function and the heart’s energy utilization while lowering oxidative stress and inflammation related to fibrosis. Enhanced calcium regulation and improved pathways for cell death are also potential benefits linked to physical activity. These insights provide a rationale for integrating exercise into treatment plans.
Nonetheless, the review cautions that existing experimental evidence does not confirm the extent or durability of these advantages in actual patients. It highlights the critical difference between theoretical benefits and proven clinical outcomes.
The review’s clinical findings mainly involve individuals with Type 2 diabetes exhibiting early cardiac abnormalities rather than those with fully developed diabetic cardiomyopathy. Among the observed benefits, combining aerobic and resistance training showed promise in enhancing cardiorespiratory fitness and insulin sensitivity, alongside improvements in vascular function and selected aspects of left ventricular performance.
High-intensity interval training may also yield additional benefits for selected patients. However, the review notes that safety and effectiveness should be evaluated on an individual basis, complicating the case for a standardized exercise plan.
Variability in exercise protocols and inconsistent reporting further complicate comparisons between different studies. The authors call for improved consistency in documenting exercise intensity using comparable physiological measures.
They advocate for a comprehensive approach to treatment response that includes cardiac imaging, functional capacity, biomarkers, glycaemic control, and any adverse effects. This would help differentiate improvements in fitness or metabolic health from changes in cardiac function, while ensuring safety is prioritized.
More adequately powered studies involving clearly defined patient groups are needed to determine the ideal exercise dosage and its long-term cardiovascular benefits. While the review positions exercise as a promising complementary strategy for managing early-stage diabetic cardiomyopathy, its role in more advanced cases remains uncertain.
Sources
My name is Kuldeep Singh Chundawat. I am an experienced content writer with several years of expertise in the field. Currently, I contribute to Daily Kiran, creating engaging and informative content across a variety of categories including technology, health, travel, education, and automobiles. My goal is to deliver accurate, insightful, and captivating information through my words to help readers stay informed and empowered.